ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $28,302,786 | +115.3% | 158,835 | +99.3% | 0.03% | +113.3% |
| Q1 2023 | $13,146,636 | +127.2% | 79,696 | +116.9% | 0.02% | +114.3% |
| Q4 2022 | $5,785,154 | -2.7% | 36,736 | -6.9% | 0.01% | -12.5% |
| Q3 2022 | $5,945,000 | -38.4% | 39,479 | -32.8% | 0.01% | -33.3% |
| Q2 2022 | $9,656,000 | -28.5% | 58,741 | -3.1% | 0.01% | -14.3% |
| Q1 2022 | $13,498,000 | +85.9% | 60,629 | +98.2% | 0.01% | +100.0% |
| Q4 2021 | $7,262,000 | -52.2% | 30,594 | -53.0% | 0.01% | -56.2% |
| Q3 2021 | $15,201,000 | -9.5% | 65,133 | -20.2% | 0.02% | -11.1% |
| Q2 2021 | $16,788,000 | +43.0% | 81,576 | +42.8% | 0.02% | +28.6% |
| Q1 2021 | $11,736,000 | +71.3% | 57,123 | +78.9% | 0.01% | +55.6% |
| Q4 2020 | $6,850,000 | +1339.1% | 31,937 | +1126.0% | 0.01% | +800.0% |
| Q3 2020 | $476,000 | -94.5% | 2,605 | -94.5% | 0.00% | -93.3% |
| Q2 2020 | $8,679,000 | +16.1% | 47,087 | +27.1% | 0.02% | -11.8% |
| Q1 2020 | $7,476,000 | +50.3% | 37,050 | +39.4% | 0.02% | +112.5% |
| Q4 2019 | $4,973,000 | +1411.6% | 26,575 | +1190.7% | 0.01% | +700.0% |
| Q3 2019 | $329,000 | -98.5% | 2,059 | -97.7% | 0.00% | -97.7% |
| Q1 2019 | $21,634,000 | +4.9% | 90,395 | +0.7% | 0.04% | -12.2% |
| Q4 2018 | $20,620,000 | -32.7% | 89,795 | -17.2% | 0.05% | -14.0% |
| Q3 2018 | $30,661,000 | +416.1% | 108,440 | +436.0% | 0.06% | +375.0% |
| Q2 2018 | $5,941,000 | +18.7% | 20,233 | +2.0% | 0.01% | +9.1% |
| Q1 2018 | $5,005,000 | +34.2% | 19,831 | +14.8% | 0.01% | +22.2% |
| Q4 2017 | $3,730,000 | +74.7% | 17,270 | +50.3% | 0.01% | +80.0% |
| Q3 2017 | $2,135,000 | +49.5% | 11,489 | +38.8% | 0.01% | +25.0% |
| Q2 2017 | $1,428,000 | -8.2% | 8,280 | -18.7% | 0.00% | 0.0% |
| Q1 2017 | $1,556,000 | +47.2% | 10,188 | +42.0% | 0.00% | +33.3% |
| Q4 2016 | $1,057,000 | +12.1% | 7,175 | -3.8% | 0.00% | 0.0% |
| Q3 2016 | $943,000 | +138.7% | 7,460 | +113.1% | 0.00% | +200.0% |
| Q2 2016 | $395,000 | -67.5% | 3,500 | -70.0% | 0.00% | -75.0% |
| Q1 2016 | $1,214,000 | -58.8% | 11,660 | -55.4% | 0.00% | -50.0% |
| Q4 2015 | $2,946,000 | +92.8% | 26,124 | +87.2% | 0.01% | +100.0% |
| Q3 2015 | $1,528,000 | +6.9% | 13,955 | -6.6% | 0.00% | 0.0% |
| Q2 2015 | $1,430,000 | +6.0% | 14,948 | +3.2% | 0.00% | 0.0% |
| Q1 2015 | $1,349,000 | -0.2% | 14,479 | -12.3% | 0.00% | -20.0% |
| Q4 2014 | $1,352,000 | -23.5% | 16,505 | -40.1% | 0.01% | -28.6% |
| Q3 2014 | $1,768,000 | +9.2% | 27,544 | +3.4% | 0.01% | 0.0% |
| Q2 2014 | $1,619,000 | -1.6% | 26,628 | -3.1% | 0.01% | 0.0% |
| Q1 2014 | $1,646,000 | +224.0% | 27,492 | +267.3% | 0.01% | +133.3% |
| Q3 2013 | $508,000 | – | 7,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |